EGF-containing pharmaceutical composition for the treatment of bronchopulmonary pathologies
US5455226A · kind A · utility
0Cited by
1References
1Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Dec 1, 1992 |
| Grant date | Oct 3, 1995 |
| Priority date | — |
| Expiry date | Dec 1, 2012 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P11/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
EGF (Epidermal Growth Factor)-containing pharmaceutical composition and method for the treatment of bronchopulmonary pathologies accompanied by lesions of the bronchial epithelium utilising EGF.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.